Today: 17 May 2026
XRP price slips as Coinbase opposition stalls key U.S. crypto bill — what traders watch next
16 January 2026
1 min read

XRP price slips as Coinbase opposition stalls key U.S. crypto bill — what traders watch next

New York, Jan 16, 2026, 10:11 AM EST — Regular session.

  • XRP dropped roughly 2% after Washington’s efforts to introduce new crypto market regulations stalled.
  • Coinbase’s CEO said the exchange can’t support the bill “in its current form.”
  • Ripple highlighted new regulatory developments in Europe this week.

XRP dropped roughly 2% to $2.06 on Friday, deepening its retreat after a U.S. Senate committee put the brakes on a broad crypto market-structure bill.

This setback is significant since the bill aims to clarify how crypto tokens are regulated in the U.S., a demand the industry has pushed for years. Such moves can swiftly shift sentiment in the large, liquid coins.

This comes amid a hectic policy week for crypto in Washington, where traders had been betting that a workable framework was just around the corner.

Bitcoin slipped roughly 0.8% to near $95,200, while ether dropped about 1.4% to around $3,300, following the broader weakness seen in leading tokens.

The Senate Banking Committee canceled a scheduled markup — where lawmakers hash out and vote on amendments — after Coinbase CEO Brian Armstrong said the exchange couldn’t back the bill as it stands. “We’d rather have no bill than a bad bill,” Armstrong stated, though he expressed hope a deal could still be struck. Reuters

The bill, called the CLARITY Act, aims to define precisely when crypto tokens qualify as securities. It also tackles the ongoing debate over stablecoin rewards—those incentives linked to dollar-pegged tokens that banks warn might siphon deposits away from conventional banking.

The Senate Banking Committee’s calendar update revealed the Jan. 15 executive session to review H.R.3633 has been postponed.

Ripple, steering clear of Capitol Hill distractions, highlighted its licensing progress. This week, the company snagged preliminary approval for an electronic money institution licence in Luxembourg, aiming to broaden its payments services throughout Europe. “The EU was amongst the first major jurisdictions to introduce comprehensive digital assets regulation,” Ripple President Monica Long noted. Ripple

For now, the most immediate risk to XRP is straightforward: if the U.S. bill stalls or is altered in ways opposed by the industry, the market could fall back into uncertainty over which regulator—and which set of rules—will take charge.

Traders are focused on key upcoming deadlines in Congress: the Senate Agriculture Committee aims to release legislative text by Jan. 21, with a committee markup set for Jan. 27. They’re also tracking any new dates from the Banking Committee.

Stock Market Today

  • Berkshire Hathaway CEO Greg Abel Revamps Portfolio with Major Stock Changes
    May 16, 2026, 7:29 PM EDT. Berkshire Hathaway, under new CEO Greg Abel, has significantly overhauled its equity portfolio in Q1, highlighted by a 224% increase in Alphabet shares, now Berkshire's seventh largest holding valued at $16.6 billion. Abel added Delta Air Lines and Macy's, while cutting multiple stocks, including a near-total sale of Constellation Brands and complete exit from Amazon shares. The largest reduction by value was in Chevron, cut by 35%, worth over $8 billion. The reshuffle marks a shift away from holdings linked to former portfolio manager Todd Combs, indicating a strategic realignment under Abel's leadership. Alphabet has gained 38% since the quarter ended.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Nvidia CEO Jensen Huang shuts down “God AI” hype — and says AI will still “eat software”
Previous Story

Nvidia CEO Jensen Huang shuts down “God AI” hype — and says AI will still “eat software”

Rocket Lab stock jumps after Morgan Stanley upgrade as RKLB tests fresh highs
Next Story

Rocket Lab stock jumps after Morgan Stanley upgrade as RKLB tests fresh highs

Go toTop